FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1799318079> ?p ?o ?g. }

• W1799318079 endingPage "220" @default.
• W1799318079 startingPage "220" @default.
• W1799318079 abstract "A pilot study was conducted in patients with advanced non-small cell lung cancer to examine whether the gene-specific damage in mononuclear cells (MNCs) incubated with cisplatin in vitro correlates with chemotherapeutic outcome in cisplatin-based chemotherapy. Twenty-one patients received cisplatin-based chemotherapy, consisting of cisplatin (80 mg/m2 i.v. on day 1), vindesine (3 mg/m2 i.v. on days 1 and 8), with or without mitomycin (8 mg/m2 i.v. on day 1). MNCs from peripheral blood were obtained from each patient before chemotherapy. The cells were incubated with cisplatin for 3 h in vitro and the 2.7-kb fragment of the hypoxanthine phosphoribosyltransferase gene was amplified by PCR for quantitation of DNA damage. There was a 4-fold interpatient variation in DNA damage in MNCs. Seven of 21 patients had a partial response to chemotherapy. When the dose of cisplatin required to reduce amplification of the hypoxanthine phosphoribosyltransferase sequence by 63% (D63 value) of MNCs was compared in each patient (defined by a Poisson distribution as the dose that produced an average of one lesion per single strand of the 2.7-kb fragment), the mean D63 value in patients showing a partial response (n = 7; 52 +/- 11 micrograms/ml) was significantly lower than that in patients showing no change (n = 10; 81 +/- 20 micrograms/ml; P = 0.0045) and in patients with disease progression (n = 4; 115 +/- 34 micrograms/ml; P = 0.0012). The mean D63 in patients with no change was also significantly lower than that in the patients with disease progression (P = 0.0386). Seven (70%) of 10 patients with a D63 value < 70 micrograms/ml were responders. No relationship was observed between the D63 values and hematological and nonhematological toxicities. It is suggested that DNA damage in MNCs incubated by cisplatin treatment in vitro in responders was greater than that in nonresponders. Gene-specific damage in MNCs from peripheral blood incubated with cisplatin in vitro assayed by PCR may predict the chemotherapeutic response in cisplatin-based chemotherapy for non-small cell lung cancer." @default.
• W1799318079 created "2016-06-24" @default.
• W1799318079 creator A5044442302 @default.
• W1799318079 creator A5047834232 @default.
• W1799318079 creator A5050855780 @default.
• W1799318079 creator A5052317767 @default.
• W1799318079 creator A5058549884 @default.
• W1799318079 creator A5078552758 @default.
• W1799318079 creator A5090809459 @default.
• W1799318079 creator A5090846902 @default.
• W1799318079 date "1995-10-01" @default.
• W1799318079 modified "2023-09-26" @default.
• W1799318079 title "Correlation of therapeutic outcome in non-small cell lung cancer and DNA damage assayed by polymerase chain reaction in leukocytes damaged in vitro" @default.
• W1799318079 cites W1517391981 @default.
• W1799318079 cites W1528896526 @default.
• W1799318079 cites W1541405335 @default.
• W1799318079 cites W1607511503 @default.
• W1799318079 cites W1973331584 @default.
• W1799318079 cites W1975323992 @default.
• W1799318079 cites W1981941146 @default.
• W1799318079 cites W1984665941 @default.
• W1799318079 cites W1984803750 @default.
• W1799318079 cites W2014896394 @default.
• W1799318079 cites W2049380097 @default.
• W1799318079 cites W2070077921 @default.
• W1799318079 cites W2076668534 @default.
• W1799318079 cites W2086154401 @default.
• W1799318079 cites W2088849418 @default.
• W1799318079 cites W2092572424 @default.
• W1799318079 cites W2093756056 @default.
• W1799318079 cites W2122716764 @default.
• W1799318079 cites W2138855878 @default.
• W1799318079 cites W2147958275 @default.
• W1799318079 cites W2150379801 @default.
• W1799318079 cites W2154498516 @default.
• W1799318079 cites W2409350589 @default.
• W1799318079 cites W2417349385 @default.
• W1799318079 doi "https://doi.org/10.1016/0169-5002(95)90679-7" @default.
• W1799318079 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7757984" @default.
• W1799318079 hasPublicationYear "1995" @default.
• W1799318079 type Work @default.
• W1799318079 sameAs 1799318079 @default.
• W1799318079 citedByCount "9" @default.
• W1799318079 countsByYear W17993180792018 @default.
• W1799318079 countsByYear W17993180792019 @default.
• W1799318079 crossrefType "journal-article" @default.
• W1799318079 hasAuthorship W1799318079A5044442302 @default.
• W1799318079 hasAuthorship W1799318079A5047834232 @default.
• W1799318079 hasAuthorship W1799318079A5050855780 @default.
• W1799318079 hasAuthorship W1799318079A5052317767 @default.
• W1799318079 hasAuthorship W1799318079A5058549884 @default.
• W1799318079 hasAuthorship W1799318079A5078552758 @default.
• W1799318079 hasAuthorship W1799318079A5090809459 @default.
• W1799318079 hasAuthorship W1799318079A5090846902 @default.
• W1799318079 hasConcept C126322002 @default.
• W1799318079 hasConcept C137061746 @default.
• W1799318079 hasConcept C143425029 @default.
• W1799318079 hasConcept C153911025 @default.
• W1799318079 hasConcept C202751555 @default.
• W1799318079 hasConcept C2776178081 @default.
• W1799318079 hasConcept C2776256026 @default.
• W1799318079 hasConcept C2776694085 @default.
• W1799318079 hasConcept C2776755627 @default.
• W1799318079 hasConcept C2777714996 @default.
• W1799318079 hasConcept C2778239845 @default.
• W1799318079 hasConcept C2779321808 @default.
• W1799318079 hasConcept C2779429289 @default.
• W1799318079 hasConcept C552990157 @default.
• W1799318079 hasConcept C55493867 @default.
• W1799318079 hasConcept C71924100 @default.
• W1799318079 hasConcept C86803240 @default.
• W1799318079 hasConcept C90924648 @default.
• W1799318079 hasConceptScore W1799318079C126322002 @default.
• W1799318079 hasConceptScore W1799318079C137061746 @default.
• W1799318079 hasConceptScore W1799318079C143425029 @default.
• W1799318079 hasConceptScore W1799318079C153911025 @default.
• W1799318079 hasConceptScore W1799318079C202751555 @default.
• W1799318079 hasConceptScore W1799318079C2776178081 @default.
• W1799318079 hasConceptScore W1799318079C2776256026 @default.
• W1799318079 hasConceptScore W1799318079C2776694085 @default.
• W1799318079 hasConceptScore W1799318079C2776755627 @default.
• W1799318079 hasConceptScore W1799318079C2777714996 @default.
• W1799318079 hasConceptScore W1799318079C2778239845 @default.
• W1799318079 hasConceptScore W1799318079C2779321808 @default.
• W1799318079 hasConceptScore W1799318079C2779429289 @default.
• W1799318079 hasConceptScore W1799318079C552990157 @default.
• W1799318079 hasConceptScore W1799318079C55493867 @default.
• W1799318079 hasConceptScore W1799318079C71924100 @default.
• W1799318079 hasConceptScore W1799318079C86803240 @default.
• W1799318079 hasConceptScore W1799318079C90924648 @default.
• W1799318079 hasIssue "2" @default.
• W1799318079 hasLocation W17993180791 @default.
• W1799318079 hasLocation W17993180792 @default.
• W1799318079 hasOpenAccess W1799318079 @default.
• W1799318079 hasPrimaryLocation W17993180791 @default.
• W1799318079 hasRelatedWork W165238446 @default.
• W1799318079 hasRelatedWork W1969918779 @default.
• W1799318079 hasRelatedWork W2054932891 @default.

• next